Redhill Biopharma Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.75
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.03
|
-0.20
|
-0.17
|
-566.67%
|
|
2022-06-30
|
-0.03
|
-0.20
|
-0.17
|
-566.67%
|
|
2022-03-31
|
-0.23
|
-0.30
|
-0.07
|
-30.43%
|
|
2021-12-31
|
-0.33
|
-0.50
|
-0.17
|
-51.52%
|
|
2021-09-30
|
-0.21
|
-0.50
|
-0.29
|
-138.10%
|
|
2021-06-30
|
-0.12
|
-0.60
|
-0.48
|
-400.00%
|
|
2021-03-31
|
-0.34
|
-0.50
|
-0.16
|
-47.06%
|
|
2020-12-31
|
-0.24
|
-0.70
|
-0.46
|
-191.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.70
|
|
2021-12-31
|
-2.10
|
|
2020-12-31
|
-2.10
|
|
2019-12-31
|
-1.45
|
|
2018-12-31
|
-1.70
|
|
2017-12-31
|
-1.51
|
|
2016-12-31
|
-2.24
|
|
2015-12-31
|
-2.00
|
|
2014-12-31
|
-1.31
|
|
2013-12-31
|
-0.88
|
|
2012-12-31
|
-0.64
|